Healthlynked Corp (HLYK) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Healthlynked Corp  (HLYK)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Healthlynked's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Healthlynked's ROI in the second quarter of 2026?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Healthlynked Corp's return on investment (ROI) in its second quarter of 2026

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 -7 8 -5 -4
Return On Investment (TTM) - - 277.03 % - -
HLYK's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -5 -4 -3 -4 -5




Return On Investment HLYK's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Healthlynked's II. Quarter Investments $ 0 Millions HLYK's Balance sheet
Healthlynked's II. Quarter Income $ -1 Millions Quarterly HLYK's Income Statement
HLYK's Income by Division See HLYK's Income by Division


HLYK Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 8 -2 10 1 9
Y / Y Investment Growth - - 820.43 % -87.4 % 167.38 %
Net Income in Millions -3 -6 -1 -9 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -40.68 % - -9.94 % -829.04 % -122.67 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HLYK's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HLYK's Competitors
Subscribers only: Roi for Healthlynked's Suppliers
Subscribers only: Return On Investment for HLYK's Customers

Other Ratios
HLYK's Roa HLYK's Inventory Turnover Ratio HLYK's Growth Rates HLYK's Dividend Statistics
HLYK's Profitability Ratios HLYK's Asset Turnover Ratio HLYK's Dividend Growth
HLYK's Roe HLYK's Valuation Ratios HLYK's Financial Strength Ratios HLYK's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Glucotrack Inc   843.28 %
Stablecoin Development Corporation  618.18 %
Omeros Corporation  198.34 %
Elutia Inc   191.75 %
Sanuwave Health Inc   167.92 %
Vor Biopharma Inc   162.71 %
Capforce Inc   161.42 %
Kyntra Bio Inc   157.74 %
Silexion Therapeutics Corp  127.60 %
Quince Therapeutics Inc   112.49 %
Pulmatrix Inc   108.83 %
Interpace Biosciences Inc   100.71 %


Date modified: 2026-09-12T06:22:34+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.